HALB x Gunderson: ECVC Law, Venture-Backed Growth, and the Anatomy of a Multibillion Dollar Acquisition

Join HALB for a fireside chat featuring Tim Ehrlich (Partner, Gunderson Dettmer) and Stuart Chaffee (formerly Chief Business Officer, Affinivax). Together, they will unpack the legal and strategic path of a venture-backed company from growth stage to multibillion-dollar acquisition. Using GSK’s acquisition of Affinivax, a deal valued at up to $3.3 billion, as a case study, this conversation will offer a behind-the-scenes look at ECVC (Emerging Companies, Venture Capital) law in practice.